Fortrea (FTRE)
Runs clinical trials and development services for drug, biotech, and device sponsors.
$20.19
vs last close−0.24 (−1.20%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 43 days
EPS estimate
$0.23
Revenue estimate
$670.5M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Jul '26Nov '26
Reported$0.18$0.02$0.19$0.12$0.09$0.16$0.23Pending
Estimate$0.36−$0.07$0.06$0.16$0.16$0.03$0.18$0.23
Surprise−50.0%+128.6%+216.7%−25.0%−43.8%+433.3%+27.5%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Jul '26Nov '26
Reported$697.0M$651.3M$710.3M$701.3M$660.5M$636.5M$678.2MPending
Estimate$661.0M$610.9M$623.4M$665.2M$665.2M$628.5M$647.6M$670.5M
Surprise+5.4%+6.6%+13.9%+5.4%−0.7%+1.3%+4.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2029 | $0.42 | — | — |
| Sep 2029 | $0.40 | — | — |
| Jun 2029 | $0.39 | — | — |
| Mar 2029 | $0.37 | — | — |
| Dec 2028 | $0.34 | — | — |
| Sep 2028 | $0.31 | — | — |
| Jun 2028 | $0.35 | — | — |
| Mar 2028 | $0.27 | — | — |
| Dec 2027 | $0.28 | — | — |
| Sep 2027 | $0.26 | — | — |
| Jun 2027 | $0.27 | — | — |
| Mar 2027 | $0.22 | — | — |
| Dec 2026 | $0.24 | — | — |
| Nov 2026 | $0.23 | — | — |
| Jul 2026 | $0.18 | $0.23 | +27.5% |
| May 2026 | $0.03 | $0.16 | +433.3% |
| Feb 2026 | $0.16 | $0.09 | −43.8% |
| Nov 2025 | $0.16 | $0.12 | −25.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2029 | $0.42 | — | — | $769.6M | — | — | — |
| Sep 2029 | $0.40 | — | — | $758.2M | — | — | — |
| Jun 2029 | $0.39 | — | — | $749.4M | — | — | — |
| Mar 2029 | $0.37 | — | — | $740.6M | — | — | — |
| Dec 2028 | $0.34 | — | — | $722.5M | — | — | — |
| Sep 2028 | $0.31 | — | — | $714.8M | — | — | — |
| Jun 2028 | $0.35 | — | — | $707.5M | — | — | — |
| Mar 2028 | $0.27 | — | — | $693.4M | — | — | — |
| Dec 2027 | $0.28 | — | — | $700.6M | — | — | — |
| Sep 2027 | $0.26 | — | — | $693.7M | — | — | — |
| Jun 2027 | $0.27 | — | — | $689.0M | — | — | — |
| Mar 2027 | $0.22 | — | — | $666.6M | — | — | — |
| Dec 2026 | $0.24 | — | — | $675.6M | — | — | — |
| Nov 5, 2026 | $0.23 | — | — | $670.5M | — | — | — |
| Jul 29, 2026 | $0.18 | $0.23 | +27.5% | $647.6M | $678.2M | +4.7% | −1.5% |
| May 5, 2026 | $0.03 | $0.16 | +433.3% | $628.5M | $636.5M | +1.3% | +18.6% |
| Feb 26, 2026 | $0.16 | $0.09 | −43.8% | $665.2M | $660.5M | −0.7% | +4.5% |
| Nov 5, 2025 | $0.16 | $0.12 | −25.0% | $665.2M | $701.3M | +5.4% | +23.2% |
| Aug 6, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 3, 2025 | |||||||
| Nov 8, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 11, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 14, 2023 | |||||||
| Jun 2, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Sep 30, 2022 | |||||||
| Jun 29, 2022 | |||||||
| Mar 30, 2022 |